#137: Innovative MS Rehabilitation Approaches – Insights from ECTRIMS 2025

#137: Innovative MS Rehabilitation Approaches – Insights from ECTRIMS 2025

In this episode, we dive into five innovative rehabilitation studies presented at ECTRIMS 2025. From the validation of digital assessments to family-centered care and home-based rehabilitation, these studies offer promising insights for people living with MS. Whether you're a patient, caregiver, or healthcare professional, this episode highlights tools and approaches that can improve quality of life, independence, and symptom management.

📰 Prefer reading instead?
👉 Check out the full blog article with all study summaries here: https://ms-perspektive.com/137-rehab-ectrims

🧠 Poster Summaries 1. Robot-based assessment of motor-cognitive dual-task abilities in unimpaired adults

Authors: E. Misley et al.
Summary:
This study validated the use of "hunova" – a robotic platform that integrates digital cognitive tests with motor tasks – in healthy adults.
Results:
Strong correlations with traditional tests, faster performance digitally, and high agreement between test types suggest this tool could be valuable in MS for real-time, objective, and combined motor-cognitive assessments.
Evidence Level: Early validation study (Level III – non-randomized).
Why it matters: Digital cognitive-motor testing could offer a faster, scalable way to detect subtle impairments in MS.

2. Evaluating Inpatient Rehabilitation at a National MS Centre in Norway

Authors: Gunnes, M. et al.
Summary:
A structured assessment of inpatient rehabilitation outcomes across multiple domains (QoL, fatigue, self-efficacy, symptoms).
Results:
Significant improvements in symptom burden, QoL, and function from admission to discharge and 6 weeks post-discharge. Some relapse after discharge indicates the need for continued support.
Evidence Level: Level II (observational, real-world data).
Why it matters: Inpatient rehab clearly benefits MS patients, but ongoing follow-up is crucial to maintain gains.

3. Combining Home-Based Digital Telerehabilitation with In-Hospital Therapy in Progressive MS

Authors: Gandolfi M. et al.
Summary:
Participants with progressive MS received both in-hospital sessions and 12 weeks of digital telerehabilitation.
Results:
Although primary motor outcomes did not show significant differences yet, patient satisfaction and acceptability of the digital program were very high.
Evidence Level: Level II (well-designed RCT, small sample).
Why it matters: A hybrid rehab model could become a scalable, patient-friendly long-term approach, especially for those with limited access to clinics.

4. Effectiveness of MS Centers vs. General Healthcare in Improving QoL

Authors: E. Grigoriadou et al.
Summary:
Compared outcomes in patients treated at MS Centers versus general healthcare settings.
Results:
MS Center patients had faster diagnoses, better MRI access, fewer delays, and higher satisfaction scores, with less anxiety and pain.
Evidence Level: Level III (observational cohort).
Why it matters: MS Centers offer significantly better coordinated care, impacting everyday wellbeing and disease progression.

5. Digital Resource Development for MS Family Caregivers (DigiTRAC Study)

Authors: Afolasade Fakolade et al.
Summary:
A co-creation study involving caregivers and service providers to design an ideal digital support platform.
Results:
Top priorities were ease of use, MS treatment info, and emotional wellbeing tools. Respondents emphasized the need for multimedia content and accessible tech.
Evidence Level: Level IV (qualitative + survey-based design).
Why it matters: Well-designed digital resources could reduce caregiver burden and improve resilience for families supporting MS patients.

💡 Key Takeaways for People with MS:
  • Digital tools are becoming more validated and practical for cognitive and motor rehab.

  • Inpatient rehab works, but consistent follow-up is needed.

  • Home-based hybrid models offer flexibility and satisfaction.

  • Where you get care matters—MS Centers outperform general care.

  • Supporting caregivers is crucial for the whole care ecosystem.

--

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(192)

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

#183: Silent progression in MS. Can we really detect it early?

#183: Silent progression in MS. Can we really detect it early?

Can we detect gradual MS progression before it becomes obvious? In this episode, I look at what current research can — and cannot — tell us about subtle worsening without an obvious relapse. The key d...

16 Sep 34min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
fryktlos
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-strid
rss-ekteskapet
rss-bisarr-historie
foreldreradet
treningspodden
jakt-og-fiskepodden
rss-kunsten-a-leve
rss-kull
rss-orjasater
sinnsyn
mikkels-paskenotter
gravid-uke-for-uke
rss-flydilla
hverdagspsyken
rss-mind-body-podden
rss-impressions-2